First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
Janjigian, Yelena Y ; Shitara, Kohei ; Moehler, Markus ; Garrido, Marcelo ; Salman, Pamela ; Shen, Lin ; Wyrwicz, Lucjan ; Yamaguchi, Kensei ; Skoczylas, Tomasz ; Campos Bragagnoli, Arinilda ; Liu, Tianshu ; Schenker, Michael ; Yanez, Patricio ; Tehfe, Mustapha ; Kowalyszyn, Ruben ; Karamouzis, Michalis V ; Bruges, Ricardo ; Zander, Thomas ; Pazo-Cid, Roberto ; Hitre, Erika ; Feeney, Kynan ; Cleary, James M ; Poulart, Valerie ; Cullen, Dana ; Lei, Ming ; Xiao, Hong ; Kondo, Kaoru ; Li, Mingshun ; Ajani, Jaffer A
Source
In The Lancet 3-9 July 2021 398(10294):27-40
Subject
Primary Research Articles
Language
ISSN
0140-6736